China Pharma Holdings CPHI
NYSE CPHI
$0.64 -0.02 (-2.62%)
As of: Oct 1, 2026 · 3:53 PM EDT

China Pharma Holdings (CPHI) Cash & Equivalents (2010 - 2026)

Updated

China Pharma Holdings' Cash & Equivalents was $304,874 in Q2 2026, down 51.2% from $625,032 a year earlier but up 79.3% from the prior quarter.

Analysis

China Pharma Holdings (CPHI) Cash & Equivalents (2010 - 2026) Analysis & Trends

At the end of FY2025, Cash & Equivalents at China Pharma Holdings came in at $345,112, down 44.9% from FY2024.

  • Cash & Equivalents has now declined for four consecutive years, with a five-year compound annual growth rate of -18.5% (FY2020 to FY2025).
  • In earlier years, Cash & Equivalents was $626,879 in FY2024 (-56.0%), $1.42 million in FY2023 (-29.9%), $2.03 million in FY2022 (-58.2%) and $4.86 million in FY2021 (+407.4%).
  • Quarterly Cash & Equivalents has moved between $170,000 (Q1 2026) and $4.86 million (Q4 2021) over five years.
  • Compared with a year earlier, Cash & Equivalents has declined for 15 straight quarters, with an average decline of 47.9% over the last eight quarters.
  • The best year-over-year quarter for Cash & Equivalents over five years was Q1 2022 (growth of 595.0%); the worst was Q1 2023 (a decline of 68.6%).
  • Per Business Quant data, CPHI's Cash & Equivalents in the three quarters before Q2 2026 was $170,000 (Q1 2026), $345,112 (Q4 2025) and $300,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 20.42 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 6.57 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 6.85 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 7.62 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 4.89 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 13.99 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 3.18 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 976.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 6.14 Bn
10 China Pharma Holdings 26.34 Mn 25.22 Mn 83,566.00 304,874.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 304,874.00
Mar 31, 2026 170,000.00
Dec 31, 2025 345,112.00
Sep 30, 2025 300,000.00
Jun 30, 2025 625,032.00
Mar 31, 2025 412,688.00
Dec 31, 2024 626,879.00
Sep 30, 2024 718,691.00
Jun 30, 2024 739,337.00
Mar 31, 2024 838,881.00
Dec 31, 2023 1.42 Mn
Sep 30, 2023 1.37 Mn
Jun 30, 2023 901,910.00
Mar 31, 2023 1.17 Mn
Dec 31, 2022 2.03 Mn
Sep 30, 2022 2.09 Mn
Jun 30, 2022 2.24 Mn
Mar 31, 2022 3.71 Mn
Dec 31, 2021 4.86 Mn
Sep 30, 2021 458,831.00
API Access

China Pharma Holdings Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=CPHI&period=max&api_key=YOUR_API_KEY